Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Freeline Therapeutics Holdings plc from Q1 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Freeline Therapeutics Holdings plc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q1 2022 to Q3 2023.
  • Freeline Therapeutics Holdings plc Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending September 30, 2023 was $675K, a 74.5% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Freeline Therapeutics Holdings plc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $675K -$1.97M -74.5% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $698K -$11.9M -94.5% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $686K -$12.9M -94.9% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $3.54M Dec 31, 2022 20-F 2023-04-04
Q3 2022 $2.64M Sep 30, 2022 6-K 2022-11-15
Q2 2022 $12.6M Jun 30, 2022 6-K 2022-08-09
Q1 2022 $13.6M Mar 31, 2022 6-K 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.